Scientists discover a key mechanism used by human herpesvirus 8 to induce cancer

FHS
March 1, 2024
7:47 pm

Cleveland Clinic researchers have discovered a key mechanism used by Kaposi’s sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8), to induce cancer.

Largest ALS patient-based iPSC repository opens new frontiers in research

In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) patient-based induced pluripotent stem

November 15, 2024

Lentiviral vector shortage looms unless manufacturing hurdles from clinical to commercial are addressed

With the anticipation that more gene therapies will enter the market, manufacturers could struggle to meet demand if lentiviral vector shortage risk is not tackled,

January 26, 2024

Emergent to sell US sterile manufacturing facility to Bora

The 87,000ft2 facility is expected to complement Bora’s existing services. Credit: Matveev Aleksandr/Shutterstock. Emergent BioSolutions has agreed to divest its sterile manufacturing facility in Baltimore-Camden,

June 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.